outdated_browser_message

Items Tagged ‘T-VEC’

January 12, 2018

Combining T-VEC Herpes Virus With Keytruda Immunotherapy Shows Promise for Treating Advanced Melanoma

By

CancerConnect News: UCLA scientists have developed a potential new treatment for melanoma that has shown promising early clinical results.  In a two-year UCLA-led study, nearly two-thirds of people with advanced melanoma responded positively to a treatment that combines the immunotherapy drug keytruda (pembrolizumab) with a herpes virus called T-VEC (talimogene laherpareovec). Researchers found that the […]

View full entry

Tags: immunotherapy, keytruda, Melanoma, News, Precision Cancer Medicine, T-VEC, targeted therapy


May 1, 2015

Melanoma Drug T-VEC Receives Recommendation for FDA Approval

By

An advisory panel to the U.S. Food and Drug Administration (FDA) has recommended approval of the investigational drug T-VEC (talimogene laherparepvec) for the treatment of metastatic melanoma. Biopharmaceutical company Amgen recently announced plans to move forward with approval process.[1] The recommendation for approval is based on findings from a Phase III clinical trial in which […]

View full entry

Tags: fda, Melanoma, News, Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma, T-VEC